Search research articles
Contact Us
Filters
Showing results (41-50 of 199) with videos related to
Page
of 20
Sort By:
Journal of the American Academy of Dermatology
|
August 19, 2017
Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status
Hildur Helgadottir, Rainer Tuominen, Håkan Olsson, et al.
Cancer Immunology, Immunotherapy : CII
|
June 27, 2014
Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy
Yago Pico de Coaña, Giuseppe Masucci, Johan Hansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2003
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression
Katarina Omholt, Anton Platz, Lena Kanter, et al.
BMJ Quality & Safety
|
November 19, 2013
Suffering in silence: a qualitative study of second victims of adverse events
Susanne Ullström, Magna Andreen Sachs, Johan Hansson, et al.
International Journal of Health Care Quality Assurance
|
May 29, 2015
Agile, a guiding principle for health care improvement?
Sara Tolf, Monica E Nyström, Carol Tishelman, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 18, 2005
Loco-regional control of cutaneous metastases of malignant melanoma by treatment with miltefosine (Miltex)
Boel Ragnarsson-Olding, Eva Djureen-Mårtensson, Eva Månsson-Brahme, et al.
Analytical and Bioanalytical Chemistry
|
April 22, 2017
Simple and cost-effective liquid chromatography-mass spectrometry method to measure dabrafenib quantitatively and six metabolites semi-quantitatively in human plasma
Svante Vikingsson, Jan-Olof Dahlberg, Johan Hansson, et al.
International Journal of Cancer
|
September 25, 2008
Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro
Malihe Eskandarpour, Fei Huang, Karen A Reeves, et al.
The International Journal of Health Planning and Management
|
August 10, 2018
Enhancing policy implementation to improve healthcare practices: The role and strategies of hybrid national-local support structures
Emma Granström, Johan Hansson, Vibeke Sparring, et al.
Cancer Research
|
May 21, 2010
Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign
Isabel Poschke, Dimitrios Mougiakakos, Johan Hansson, et al.
Page
of 20
Search research articles
Search
Showing results (41-50 of 199) with videos related to
Sort By:
Page
of 20
Journal of the American Academy of Dermatology
|
August 19, 2017
Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status
Hildur Helgadottir, Rainer Tuominen, Håkan Olsson, et al.
Cancer Immunology, Immunotherapy : CII
|
June 27, 2014
Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy
Yago Pico de Coaña, Giuseppe Masucci, Johan Hansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2003
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression
Katarina Omholt, Anton Platz, Lena Kanter, et al.
BMJ Quality & Safety
|
November 19, 2013
Suffering in silence: a qualitative study of second victims of adverse events
Susanne Ullström, Magna Andreen Sachs, Johan Hansson, et al.
International Journal of Health Care Quality Assurance
|
May 29, 2015
Agile, a guiding principle for health care improvement?
Sara Tolf, Monica E Nyström, Carol Tishelman, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 18, 2005
Loco-regional control of cutaneous metastases of malignant melanoma by treatment with miltefosine (Miltex)
Boel Ragnarsson-Olding, Eva Djureen-Mårtensson, Eva Månsson-Brahme, et al.
Analytical and Bioanalytical Chemistry
|
April 22, 2017
Simple and cost-effective liquid chromatography-mass spectrometry method to measure dabrafenib quantitatively and six metabolites semi-quantitatively in human plasma
Svante Vikingsson, Jan-Olof Dahlberg, Johan Hansson, et al.
International Journal of Cancer
|
September 25, 2008
Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro
Malihe Eskandarpour, Fei Huang, Karen A Reeves, et al.
The International Journal of Health Planning and Management
|
August 10, 2018
Enhancing policy implementation to improve healthcare practices: The role and strategies of hybrid national-local support structures
Emma Granström, Johan Hansson, Vibeke Sparring, et al.
Cancer Research
|
May 21, 2010
Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign
Isabel Poschke, Dimitrios Mougiakakos, Johan Hansson, et al.
Page
of 20